Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
<p><strong>Introduction:</strong><br /> Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies ar...
Príomhchruthaitheoirí: | Shi, L, Westwood, S, Baird, A, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N, Morgan, A, Bos, I, Vos, S, Buckley, N, Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E, Sleegers, K, Frisoni, G, Blin, O, Richardson, J, Bordet, R, Molinuevo, J, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B, Streffer, J, Visser, P, Bertram, L, Lovestone, S, Nevado-Holgado, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2019
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
de réir: Westwood, S, et al.
Foilsithe / Cruthaithe: (2020) -
Inflammatory biomarkers in Alzheimer's disease plasma
de réir: Morgan, A, et al.
Foilsithe / Cruthaithe: (2019) -
Assessment of variability in the plasma 7k SomaScan proteomics assay
de réir: Julián Candia, et al.
Foilsithe / Cruthaithe: (2022-10-01) -
MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
de réir: ten Kate, M, et al.
Foilsithe / Cruthaithe: (2018) -
Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
de réir: Delvenne, A, et al.
Foilsithe / Cruthaithe: (2024)